Onyx Biotec (NSE:ONYX) Accounts Payable: ₹176.5 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONYX Onyx Biotec Ltd NSE:ONYX
13 GF Score
Price ₹37.05
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec Accounts Payable?

Onyx Biotec NSE:ONYX +1.65% 13 Accounts Payable is ₹176.5 Mil as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review.

Onyx Biotec's Accounts Payable for the quarter that ended in Mar. 2026 was ₹176.5 Mil.

Onyx Biotec's quarterly Accounts Payable declined from Mar. 2025 (₹167.3 Mil) to Sep. 2025 (₹143.0 Mil) but then increased from Sep. 2025 (₹143.0 Mil) to Mar. 2026 (₹176.5 Mil).

Onyx Biotec's annual Accounts Payable increased from Mar. 2024 (₹137.9 Mil) to Mar. 2025 (₹167.3 Mil) and increased from Mar. 2025 (₹167.3 Mil) to Mar. 2026 (₹176.5 Mil).

Onyx Biotec Accounts Payable Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Accounts Payable Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
43.16 69.23 137.86 167.31 176.46

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial 137.86 0.00 167.31 143.00 176.46
NSE:ONYX
13GF Score
Onyx Biotec Ltd NSE:ONYX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹176.5 Mil mean?
Onyx Biotec (NSE:ONYX) has a Accounts Payable of ₹176.5 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Onyx Biotec and its competitors.
Is Onyx Biotec's Accounts Payable too high?
Onyx Biotec's current Accounts Payable is ₹176.5 Mil. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Accounts Payable compare to ISRG and BDX?
Onyx Biotec's Accounts Payable of ₹176.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Onyx Biotec and its competitors. Onyx Biotec's current Accounts Payable is ₹176.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Accounts Payable of ₹176.5 Mil. The current Accounts Payable is ₹176.5 Mil. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Accounts Payable is ₹176.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score

Get the complete analysis for NSE:ONYX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.05
Price